New Phase 3 Data Show Anti-TNF Alpha SIMPONI ARIA ® (golimumab) Significantly Improved Arthritis And Skin Manifestations In Patients With Active Psoriatic Arthritis

Treatment with SIMPONI ARIA ® Showed Significant Inhibition in the Progression of Structural Damage
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news